# Kiyohisa Hirano

> Kiyohisa Hirano is a Series A investor at Daiwa Corporate Investment backing Artificial Intelligence. See 3 investments, check sizes, portfolio. Updated Aug…

- Type: Angel Investor
- Fund: [Daiwa Corporate Investment](https://shizune.co/investors/profile/daiwa-corporate-investment)
- Location: Tokyo, Japan
- Total investments: 3
- Last investment: Feb 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kiyohisa-hirano-bb381158/

Kiyohisa Hirano is a Series A investor at Daiwa Corporate Investment in Tokyo focused on Artificial Intelligence and Legal. Kiyohisa Hirano - President and CEO @ Daiwa Corporate Investment

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 2 | 67% |
| Legal | 1 | 33% |
| Medical | 1 | 33% |
| Oncology | 1 | 33% |
| Electronics | 1 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TopoLogic | TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials. | $4.7M | Series A | Feb 29, 2024 |  |
| Lisse | Lisse offers legal business innovation through the use of AI. | $4.8M | Venture - Series Unknown | Nov 24, 2021 |  |
| Craif | Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for manycancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis. |  | Series A | Jun 17, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 2 deals together
- [Aflac Global Ventures](https://shizune.co/investors/profile/aflac-corporate-ventures) — VC Fund, 1 deal together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 1 deal together
- [FF APAC Scout](https://shizune.co/investors/profile/ff-apac-scout) — VC Fund, 1 deal together
- [Global Brain Corporation](https://shizune.co/investors/profile/global-brain-corporation) — VC Fund, 1 deal together
- [IT-Farm](https://shizune.co/investors/profile/it-farm) — VC Fund, 1 deal together

## About Daiwa Corporate Investment

VC Fund · Tokyo, Japan

Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stockexchange listings.

4 contacts available at Daiwa Corporate Investment.

| Name | Title | Profile |
| --- | --- | --- |
| Kiyohisa Hirano | President and CEO | https://shizune.co/investors/profile/kiyohisa-hirano |
| Keita Niihara | Deputy General Manager | https://shizune.co/investors/profile/keita-niihara |
| Nakamura Shogo | Head | https://shizune.co/investors/profile/shingo-nakamura |
| Nakamura Shogo | Head | https://shizune.co/investors/profile/nakamura-shogo |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Kiyohisa Hirano invest in?

Kiyohisa Hirano invests primarily in Artificial Intelligence, Legal and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kiyohisa Hirano last invest?

The most recent investment recorded for Kiyohisa Hirano closed in Feb 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co